EGFR and non-small cell lung carcinoma: On the other hand, Schrock et al. observed in NSCLC patients that a lower MSAF level was associated with a higher risk of missing important genomic alterations in the plasma, such as exon 19 deletion and p.Thr790Met substitution in the EGFR gene [47].